More than 180 million people in the world have hepatitis C, compared with the 34 million with HIV/AIDS and the roughly 30,000 who have had Ebola. Yet very little is heard about the hepatitis C virus (HCV) in the way of awareness ...
Feb 4, 2015
0
12
Thirty-eight of 40 volunteers with hepatitis C virus (HCV) infections who received a combination of three direct-acting oral drugs for six weeks were cured in a clinical trial conducted at the National Institutes of Health ...
Jan 12, 2015
0
14
(HealthDay)—Many hepatitis C patients get "lost" in the U.S. health care system, a new study suggests.
Jan 11, 2015
0
42
A 24-week course of sofosbuvir and ribavirin can eliminate hepatitis C virus (HCV) infection in two-thirds of patients who undergo liver transplantation, with positive consequences on their short- and long-term prognoses, ...
Jan 9, 2015
0
7
One of the most common causes of hepatitis A (formerly known as infectious hepatitis) is a hepatitis C virus infection in the liver. The disease can be treated medically, but not all patients are cured by the treatment currently ...
Dec 23, 2014
0
0
A new study shows that many patients infected with the hepatitis C virus (HCV) are lost during different stages of health care to manage the disease. This real-life' view of the HCV patient care continuum in a major U.S. ...
Dec 18, 2014
0
0
A new treatment developed by Walter and Eliza Hall Institute researchers to promote the cure of chronic hepatitis B virus (HBV) infection is now recruiting patients for a phase I/2a clinical trial.
Dec 15, 2014
0
1
Advances in treatment for human immunodeficiency virus (HIV) have made it possible for people with HIV to survive much longer. As they age, however, many experience impaired thinking, memory loss, mood swings and other evidence ...
Dec 11, 2014
0
0
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Dec 10, 2014
0
0
A Spanish researcher has collaborated on a mathematical analysis, recently published in the journal Science Translational Medicine, which concludes that joint therapy to counter HIV in patients who also have hepatitis C increases ...
Dec 3, 2014
0
0
